Abstract
Impairment of cell-mediated immunity in patients with primary central nervous system (CNS) tumors has repeatedly been reported but data to demonstrate the undelying immunological defect are not univocal. This report concerns a series of 31 patients harboring a glioma in which we studied:
-
1)
peripheral blood Tlymphocyte subpopulations by monoclonal antibody analysis;
-
2)
cellular responsiveness to mitogens
-
3)
serum immunoglobulin values.
The same parameters were also evaluated in 7 cases of intracranial meningioma and in 8 patients affected by non-proliferative, non-inflammatory CNS diseases. Thirty age-matched healthy volunteers formed the control group.
Neither impairment of Tcells as regard to number, responsiveness and subsets, nor abnormal Ig values were found in these groups. However two patients, harboring respectively a third ventricle low grade astrocytoma and an anterior callosal glioblastoma, presented a striking Tcells impairment. These findings might suggest a correlation between hypothalamus and immune system, as already postulated by several previous experimental and clinical studies.
Similar content being viewed by others
References
Mahaley MS, Brooks WH, Roszman TL, Daniel DB, Andka C, Richardson S: Immunobiology of primary intracranial tumors, part I: studies of cellular and humoral general immunocompetence of brain tumor patients. J Neurosurg 46:467–476, 1977
Brooks WH, Roszman TL, Rogers AS: Impairment of rosette forming T -lymphocytes in patients with primary intracranial tumors. Cancer 37:1869–1873, 1976
Brooks WH, Roszman TL, Mahaley MS, Woosley RE: Immunobiology of primary intracranial tumors: II. Analysis of lymphocyte subpopulations in patients with primary brain tumors. Clin Exp Immunol 29:61–66, 1977
Brooks WH, Netsky MG, Horwitz DA, Normansell DE: Cell-mediated immunity in patients with primary brain tumors. J Exp Med 136:1631–1639, 1972
Braun DP, Penn RD, Flannery AM, Harris JE: Immunoregulatory cell-function in peripheral blood leukocytes of patients with intracranial gliomas. Neurosurgery 10:203–205, 1982
Gerosa M, Semenzato G, Amadori G, Olivi A, Rotilio A, Tuccarello M, Iraci G: Long term immunological investigation of malignant intracranial gliomas. Surg Neurol 16:48–52, 1981
Roszman TL, Brooks WH: Immunobiology of primary intracranial tumors -IIII. Demonstration of a qualitative lymphocyte abnormality in patients with primary brain tumors. Clin Exp Immunol 39:395–401, 1980
Elliott LH, Brooks WH, Roszman TL: Cytokinetic basis for the impaired activation of lymphocytes from patients with primary intracranial tumors. J Immunol 132:1208–1215, 1984
Wahlstrom T. Sensitivity to normal brain antigens of blood lymphocytes from patients with gliomas. Acta Pathol Microbiol Scand 81B:763–767, 1973
Young HF, Sakalas R, Kaplan AM: Inhibition of cell-mediated immunity in patients with brain tumors. Surg Neurol 5:19–23, 1976
Fontana A, Kristensen F, Dubs R, Gemsa D, Weber E: Production of prostaglandin E and an interleukin-l-like factor by cultured astrocytes and C6 glioma cells. J Immunol 129:2413–2419, 1982
Fontana A, Hengartner H, de Tribolet N, Weber E: Glioblastoma cells release interleukin 1 and factors inhibiting Interleukin 2-mediated effects. J Immunol 132:1837–1844, 1984
Lauro GM, Di Lorenzo N, Grossi M, Maleci A, Guidetti B: Prostaglandin E2 as an immunomodulating factor released in vitro by human glioma cells. Acta Neuropathol 69:278–282, 1986
Gerosa MA, Olivi A, Rosemblum MC, Semenzato GP, Pezzutto A: Impaired immunocompetence in patients with malignant gliomas: the possible role of Tg-lymphocyte subpopulations. Neurosurgery 10:571–573, 1982
Roszman TL, Brooks WH, Elliot CH: Immunobiology of primary intracranial tumors. IV. Suppressor cell function and lectin-binding lymphocyte subpopulations in patients with cerebral tumors. Cancer 50:1273–1279, 1982
Reinherz EL, Kung PG, Goldstein G: Separation of functional subsets of human T -cells by a monoclonal antibody. Proc Nat Acad Sci USA 76:4061–4065, 1979
Krill MP, Apuzzo MLJ: Observation in the study of T-lymphocyte subsets by monoclonal antibodies and flow cytometric analysis in intracranial neoplastic disorders. Clin Neurosurg 30:125–136, 1983
Jondal M, Holm G, Wigzell H: Surface markers on human T and B-lymphocytes. I. A large population of lymphocytes forming non-immune rosettes with sheep red blood cells. J Exp Med 136:207–215, 1972
Leung DYM, Rhodes AR, Geha RV: Enumeration of T-cell subsets in atopic dermatitis using monoclonal antibodies. J Allergy Clin Immunol 67:450–455, 1981
Businco L, Pandolfi F, Rossi P, Quinti I, Aiuti F: Selective defect of a T -helper subpopulation in severe Immunocombined Immunodeficiency. J Clin Immunol 1:125–130, 1981
Apuzzo ML, Mitchell MS: Immunological aspects of intrinsec glial tumors. J Neurosurg 55:1–18, 1981
Reinherz EL, Moretta L, Roper M, Breard JM, Mingari MC, Cooper MD, Schlossman SF: Human T-lymphocyte subpopulations defined by Fc-receptors and monoclonal antibodies. J Exp Med 151:969–974, 1980
Servadei F, Parente R, Bucci M, Beltrandi E, Tognetti F, Gaist G: Particular features of cell-mediated immunity in patients with anaplastic gliomas. J Neuro Oncol I:327–332, 1983
Wood GW, Morantz RA: Depressed T -lymphocyte function in brain tumor patients: monocytes as suppressor cells. J Neuro Oncol 1:87–94, 1983
Larsson I, Landstrom LE, Larner E, Lundgren E, Miorner M, Strannegard O: Interferon production in glia and glioma cell lines. Infect Immun 22:786–789, 1978
Cross RJ, Markesbury WR, Brooks WH, Roszman TL: Hypothalamic immune interaction -I. The acute effects of anterior hypothalamic lesions on the immune response. Brain Rev 196:79–87, 1980
Saxena QB, Saxena RK, Adler WH: Regulation of NK activity in vitro. Int Archs Allergy Suppl Immun 67:169–174, 1982
Forni G, Bindoni M, Santoni A, Belluardo N, Marchese AE, Giovanelli M: Radiofrequency destruction of the tuberoinfundibolar region of the hypothalamus permanently abrogates NK cell activity in mice. Nature 306:286–290, 1983
Gupta S, Fikrig SM, Noval MS: Immunological studies in patients with isolated growth hormone deficiency. Clin Exp Immunol 54:87–90, 1983
Roszman TL, Jackson JC, Cross RJ, Titus MJ, Markesbery WR, Brooks WH: Neuroanatomic and neurotransmitter influences on immune function. J Immunol 135:769s–772s, 1985
Brooks WH, Caldwell HD, Mortara RH: Immune Responses in Patients with Gliomas. Surg Neurol 2:419–423, 1974
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Palmas, L., Moschese, V., Galli, E. et al. Immunological studies in patients with central nervous system tumors. J Neuro-Oncol 5, 29–35 (1987). https://doi.org/10.1007/BF00162762
Issue Date:
DOI: https://doi.org/10.1007/BF00162762